Oncolytic virus treatment differentially affects the CD56dim and CD56bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity
M. Wantoch, E. B. Wilson, A. P. Droop…·G. P. Cook
This study shows reovirus treatment affects CD56dim and CD56bright NK cell subsets differently, modulating their activity and signaling pathways in vivo.